Patents by Inventor Martin Schleef

Martin Schleef has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9382552
    Abstract: The invention relates to a minicircle transfer vector for producing viral vectors comprising a transfer sequence and specific packing signals flanking both sides of the transfer sequence for packaging of the transfer sequence into particles of a viral vector. The invention also relates to minicircle packaging vectors carrying support functions for producing viral vectors. The invention further relates to cells bearing the disclosed minicircles. The invention further relates to methods for producing viral vectors using such minicircles and viral vectors obtained thereby, as well as kits useful in performing the described methods.
    Type: Grant
    Filed: October 15, 2014
    Date of Patent: July 5, 2016
    Assignee: PlasmidFactory GmbH + Co KG
    Inventor: Martin Schleef
  • Publication number: 20150218586
    Abstract: The invention relates to a minicircle transfer vector for producing viral vectors comprising a transfer sequence and specific packing signals flanking both sides of the transfer sequence for packaging of the transfer sequence into particles of a viral vector. The invention also relates to minicircle packaging vectors carrying support functions for producing viral vectors. The invention further relates to cells bearing the disclosed minicircles. The invention further relates to methods for producing viral vectors using such minicircles and viral vectors obtained thereby, as well as kits useful in performing the described methods.
    Type: Application
    Filed: October 15, 2014
    Publication date: August 6, 2015
    Applicant: PLASMIDFACTORY GMBH & CO. KG
    Inventor: MARTIN SCHLEEF
  • Patent number: 6664078
    Abstract: The present invention relates to the production of biomass for the isolation of ccc plasmid DNA comprising culturing a bacterial transformant in a bioreactor containing an antibiotic-free batch medium under batch-conditions and, at the end of the batch phase, feeding under feed-back conditions the portion of a feed-back medium after the rise of the concentration of dissolved oxigen above a threshold-set point. Said feed-back medium comprises besides a carbon source a magnesium salt, preferably in concentrations above 20 mM. Preferably, the bacterial transformant is harvested after the end of the culture and frozen or freeze-dried. Also preferred is that ccc plasmid DNA is, optionally directly, isolated after harvesting the bacteria.
    Type: Grant
    Filed: November 21, 2000
    Date of Patent: December 16, 2003
    Assignee: Qiagen GmbH
    Inventors: Torsten Schmidt, Karl Friehs, Erwin Flaschel, Martin Schleef